Prognostic benefit of TILs independent of clinicopathological and molecular factors

Br J Cancer. 2023 Sep;129(5):737-738. doi: 10.1038/s41416-023-02335-6. Epub 2023 Jul 13.

Authors

Koen Brummel^#¹, Anneke L Eerkens^#¹, Marco de Bruyn¹, Hans W Nijman²

Affiliations

¹ Department of Obstetrics and Gynecology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
² Department of Obstetrics and Gynecology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. [email protected].

^# Contributed equally.

No abstract available

Publication types

Letter
Comment

MeSH terms

Disease-Free Survival
Humans
Lymphocytes, Tumor-Infiltrating* / pathology
Prognosis